Shares of Inhibikase Therapeutics, Inc. (NYSE:IKT – Get Free Report) dropped 12.4% during trading on Thursday . The company traded as low as $2.05 and last traded at $2.05. Approximately 53,482 shares were traded during mid-day trading, an increase of 23% from the average daily volume of 43,403 shares. The stock had previously closed at […]
Confluent, Inc. (NASDAQ:CFLT – Get Free Report) CTO Chad Verbowski sold 8,745 shares of Confluent stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $32.14, for a total value of $281,064.30. Following the transaction, the chief technology officer now directly owns 435,322 shares in the […]
Inhibikase Therapeutics (NYSE:IKT – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Inhibikase Therapeutics’ Q3 2023 earnings at ($1.12) EPS, Q4 2023 earnings at ($1.17) EPS, FY2023 […]
Shares of Alector, Inc. (NASDAQ:ALEC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price […]
Resolute Advisors LLC bought a new position in Valens Semiconductor Ltd. (NYSE:VLN – Free Report) in the first quarter, HoldingsChannel reports. The institutional investor bought 10,000 shares of the company’s stock, valued at approximately $32,000. A number of other institutional investors and hedge funds have also modified their holdings of the business. Clal Insurance Enterprises […]